Lilly\'s Cyramza hits Phase 3 endpoint in firstline metastatic LungCancer treatment httpbit.ly2NYCmT4Â pharma cancer

Lilly's Cyramza hits Phase 3 endpoint in first-line metastatic #LungCancer treatment http://bit.ly/2NYCmT4  #pharma #cancer

14:15 EDT 13 Mar 2019 | Pharmafile

Lilly's Cyramza hits Phase 3 endpoint in first-line metastatic #LungCancer treatment http://bit.ly/2NYCmT4  #pharma #cancer

More From BioPortfolio on "Lilly's Cyramza hits Phase 3 endpoint in first-line metastatic #LungCancer treatment http://bit.ly/2NYCmT4  #pharma #cancer"